
Nadeem Riaz, MD, M.Sc.
Lab PI
Physician-scientist, training the next generation
Integrates DDR and immunogenomics; clinical focus on HPV‑related head and neck cancer.
People
Clinicians, scientists, and computational biologists partnering to decode DDR-guided tumor immunity and deliver precision cancer treatments.
Lab PI
Physician-scientist, training the next generation
Integrates DDR and immunogenomics; clinical focus on HPV‑related head and neck cancer.
Computational scientists, biologists, and research staff decoding DDR-immunity crosstalk and adaptive therapy signals.
Senior Research Scientist
Studies the interface between homologous recombination and immuno‑oncology.
Leads mechanistic studies uncovering how DDR rewires immune recognition in HPV-associated disease.
Research Technician
Operations lead keeping the lab organized
Ensures biospecimen pipelines, data handoffs, and study operations run smoothly across collaborations.
Senior Research Scientist
Computational genomics
Dissects mutational signatures and HPV-related oncogenesis to identify new treatment approaches.
Computational Postdoctoral Fellow
Tumor microbiome and DNA‑repair signatures
Studying the tumor microbiome and tumor microenvironment in head and neck cancers.
Postdoctoral Fellow
Physician-Scientist, Medical Oncologist
Studying the DDR influence on the tumor microenvironment (TME) in breast and HRD-related cancers.
Junior faculty and physician scientists who partner with us on translational projects.
Instructor
Physician-Scientist, MSKCC
Studying the biology behind precision radiotherapy in HPV-related oropharyngeal cancers.
Assistant Attending
Radiation Oncologist, MSKCC
Collaborating on translational trials elucidating how to alter the tumor microenvironment (TME) in head and neck cancer.
Assistant Attending
Radiation Oncologist, MSKCC
Studying the tumor microenvironment (TME) of cervical cancer and how it influences radiotherapy.
Assistant Attending
Radiation Oncologist, MSKCC
Investigating how radiation reshapes the immune system in metastatic cancer.
Resident Physician-Scientist
Memorial Sloan Kettering Cancer Center
Developing methods to evaluate how radiotherapy impacts tumor evolution and immune response.
Former lab members now extending DDR biology across industry and academia.
Now: Assistant Attending (MSKCC)
Radiotherapy and synthetic cytotoxicity
Studied how to radiosensitize HR-deficient tumors in cellular models and clinical trials.
Now: Private practice
Radiotherapy and synthetic cytotoxicity
Studied radiosensitization of ATM‑deficient tumors with ATR inhibition.
Now: Industry Scientist (Colgate)
DNA repair biology
Studied homologous recombination deficiency in pancreatic cancer.
Now: Industry Scientist
Applied germline genetics
Mapped how germline variants influence cancer development.
Now: Industry Scientist (Regeneron)
Former senior lab technician
Handled translational genetic analysis and cellular DNA repair assays within the lab.
Now: Industry Scientist (Safecore Devices)
Focused on DNA repair therapeutics
Worked on mutational signatures in HRD tumors and other DNA repair tumors in cancer.
A few snapshots from lab retreats, celebrations, and team-building adventures.